Persistent acute tubular toxicity after switch from conventional amphotericin B to liposomal amphotericin B (Ambisome).
Gerbaud
Edouard
E
Tamion
Fabienne
F
Girault
Christophe
C
Clabault
Karine
K
Lepretre
Stephane
S
Leroy
Jacques
J
Bonmarchand
Guy
G
D000328:Adult; D000666:Amphotericin B / Q000008:administration & dosage* / Q000009:adverse effects*; D000935:Antifungal Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced* / Q000473:pathology; D007684:Kidney Tubules / Q000473:pathology; D007948:Leukemia, Monocytic, Acute / Q000150:complications; D008081:Liposomes; D008297:Male; D012964:Sodium / Q000652:urine; D014667:Vasopressins / Q000097:blood
D000935:Antifungal Agents; D008081:Liposomes; D014667:Vasopressins; D000666:Amphotericin B; D012964:Sodium